Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Eero Kaasinen, Hans Wijkström, Erkki Rintala, Oddvar Mestad, Staffan Jahnson & Per-Uno Malmström. (2016) Seventeen-year follow-up of the prospective randomized Nordic CIS study: BCG monotherapy versus alternating therapy with mitomycin C and BCG in patients with carcinoma in situ of the urinary bladder. Scandinavian Journal of Urology 50:5, pages 360-368.
Read now
Read now
Articles from other publishers (11)
Tatsushi Kawada, Takafumi Yanagisawa, Kensuke Bekku, Ekaterina Laukhtina, Markus von Deimling, Marcin Chlosta, Benjamin Pradere, Jeremy Yuen-Chun Teoh, Marko Babjuk, Motoo Araki & Shahrokh F. Shariat. (2023) The efficacy and safety outcomes of lower dose BCG compared to intravesical chemotherapy in non–muscle-invasive bladder cancer: A network meta-analysis. Urologic Oncology: Seminars and Original Investigations 41:6, pages 261-273.
Crossref
Crossref
Sandeep Gupta, Avisek Dutta & Dilip Kumar Pal. (2021) Comparison of intravesical adjuvant therapy in bladder cancer with two different maintenance regimens of mitomycin and BCG. Urologia Journal 89:1, pages 53-57.
Crossref
Crossref
Stefanie Schmidt, Frank Kunath, Bernadette Coles, Desiree Louise Draeger, Laura-Maria Krabbe, Rick Dersch, Samuel Kilian, Katrin Jensen, Philipp Dahm & Joerg J Meerpohl. (2020) Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Ashish M. Kamat, Joaquim Bellmunt, Matthew D. Galsky, Badrinath R. Konety, Donald L. Lamm, David Langham, Cheryl T. Lee, Matthew I. Milowsky, Michael A. O’Donnell, Peter H. O’Donnell, Daniel P. Petrylak, Padmanee Sharma, Eila C. Skinner, Guru Sonpavde, John A. Taylor, Prasanth Abraham & Jonathan E. Rosenberg. (2017) Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma. Journal for ImmunoTherapy of Cancer 5:1.
Crossref
Crossref
Tuo Deng, Bing Liu, Xiaolu Duan, Tao Zhang, Chao Cai & Guohua Zeng. (2017) Systematic Review and Cumulative Analysis of the Combination of Mitomycin C plus Bacillus Calmette-Guérin (BCG) for Non–Muscle-Invasive Bladder Cancer. Scientific Reports 7:1.
Crossref
Crossref
Dickon Hayne, Martin Stockler, Steve P. McCombie, Nicola Lawrence, Andrew Martin, Shomik Sengupta & Ian D. Davis. (2017) BCG + Mitomycin trial for high-risk non-muscle-invasive bladder cancer: progress report and lessons learned. BJU International 119, pages 55-57.
Crossref
Crossref
Chuanjun Zhuo, Xubin Li, Hongqing Zhuang, Shunli Tian, Hailong Cui, Ronghuan Jiang, Chuanxin Liu, Ran Tao & Xiaodong Lin. (2016) Evaluating the efficacy and safety of intravesical chemotherapies for non-muscle invasive bladder cancer: a network meta-analysis. Oncotarget 7:50, pages 82567-82579.
Crossref
Crossref
Riikka Järvinen, Timo Marttila, Eero Kaasinen, Erkki Rintala, Sirpa Aaltomaa, Jukka Kallio, Tapani Liukkonen, Veli-Matti Puolakka, Marjo Seppänen, Kari Tuhkanen, Markku Vaarala, Jouko Viitanen & Peter J. Boström. (2015) Long-term Outcome of Patients with Frequently Recurrent Non–muscle-invasive Bladder Carcinoma Treated with One Perioperative Plus Four Weekly Instillations of Mitomycin C Followed by Monthly Bacillus Calmette-Guérin (BCG) or Alternating BCG and Interferon-α2b Instillations: Prospective Randomised FinnBladder-4 Study. European Urology 68:4, pages 611-617.
Crossref
Crossref
Rowan G. Casey, James W.F. Catto, Liang Cheng, Michael S. Cookson, Harry Herr, Sharokh Shariat, J. Alfred Witjes & Peter C. Black. (2015) Diagnosis and Management of Urothelial Carcinoma In Situ of the Lower Urinary Tract: A Systematic Review. European Urology 67:5, pages 876-888.
Crossref
Crossref
Shao-Kuan ChenChih-Ang ChungYu-Che ChengChi-Jung HuangWen-Yih ChenRuoh-Chyu RuaanChuan LiChia-Wen TsaoWei-Wen HuChih-Cheng Chien. (2014) Toll-Like Receptor 6 and Connective Tissue Growth Factor Are Significantly Upregulated in Mitomycin-C-Treated Urothelial Carcinoma Cells Under Hydrostatic Pressure Stimulation. Genetic Testing and Molecular Biomarkers 18:6, pages 410-416.
Crossref
Crossref
Shimiao Zhu, Yang Tang, Kai Li, Zhiqun Shang, Ning Jiang, Xuewu Nian, Libin Sun & Yuanjie Niu. (2013) Optimal schedule of bacillus calmette-guerin for non-muscle-invasive bladder cancer: a meta-analysis of comparative studies. BMC Cancer 13:1.
Crossref
Crossref